| CECR |
|
cat eye syndrome chromosome region
|
|
|
0.599 |
0.731 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| MIR132 |
|
microRNA 132
|
|
|
0.485 |
0.846 |
| MDD1 |
|
Major depressive disorder
|
|
|
0.682 |
0.308 |
| BDNF-AS |
|
BDNF antisense RNA
|
|
|
0.638 |
0.538 |
| ECT |
|
centralopathic epilepsy
|
|
|
0.626 |
0.423 |
| LINC02210-CRHR1 |
P34998
|
LINC02210-CRHR1 readthrough
|
|
|
0.570 |
0.692 |
| MTCO2P12 |
|
MT-CO2 pseudogene 12
|
|
|
0.368 |
0.962 |
| LOC110806262 |
|
solute carrier family 6 member 4 gene promoter
|
|
|
0.626 |
0.423 |
| WFS1 |
O76024
|
wolframin ER transmembrane glycoprotein
|
|
1.6E-38 |
0.528 |
0.846 |
| ACE |
P12821
|
angiotensin I converting enzyme
|
Enzyme
|
1.0E-37 |
0.328 |
0.923 |
| BRCA1 |
P38398
|
BRCA1 DNA repair associated
|
Enzyme
|
9.2E-29 |
0.367 |
0.923 |
| ENPEP |
Q07075
|
glutamyl aminopeptidase
|
Enzyme
|
1.4E-28 |
0.564 |
0.731 |
| PKD2L1 |
Q9P0L9
|
polycystin 2 like 1, transient receptor potential cation channel
|
Ion channel
|
1.6E-27 |
0.565 |
0.731 |
| RMDN2 |
Q96LZ7
|
regulator of microtubule dynamics 2
|
|
4.4E-24 |
0.531 |
0.769 |
| INSRR |
P14616
|
insulin receptor related receptor
|
Kinase
|
5.4E-24 |
0.508 |
0.808 |
| SLC26A4 |
O43511
|
solute carrier family 26 member 4
|
Transporter
|
9.0E-22 |
0.507 |
0.885 |
| WDHD1 |
O75717
|
WD repeat and HMG-box DNA binding protein 1
|
Nucleic acid binding
|
4.4E-18 |
0.529 |
0.846 |
| APOB |
P04114
|
apolipoprotein B
|
|
1.9E-16 |
0.453 |
0.808 |
| ENDOU |
P21128
|
endonuclease, poly(U) specific
|
|
3.2E-14 |
0.682 |
0.423 |
| BCHE |
P06276
|
butyrylcholinesterase
|
|
1.1E-13 |
0.447 |
0.923 |
| BCS1L |
Q9Y276
|
BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone
|
|
4.7E-13 |
0.534 |
0.808 |
| KRT7 |
P08729
|
keratin 7
|
|
3.1E-12 |
0.463 |
0.808 |
| ANKK1 |
Q8NFD2
|
ankyrin repeat and kinase domain containing 1
|
Kinase
|
7.4E-12 |
0.604 |
0.462 |
| GC |
P02774
|
GC vitamin D binding protein
|
Transporter
|
2.7E-11 |
0.489 |
0.885 |